Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | HPGD | P15428 | 5/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.48 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.48 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.48 |
| ▸ | GUSB | P08236 | 7/20 | 0.47 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.45 |
| ▸ | FYN | P06241 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | AHR | P35869 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1618747 | 0.85 | ALDH1A1 (0.43) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL8371939 | 0.83 | ALDH1A1 (0.50) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL8371940 | 0.83 | ALDH1A1 (0.50) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL16177228 | 0.79 | ALDH1A1 (0.50) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL5830296 | 0.79 | ALDH1A1 (0.52) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL15480135 | 0.79 | GUSB (0.53) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL64873 | 0.78 | ALDH1A1 (0.48) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL1032488 | 0.78 | ALDH1A1 (0.48) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL16807027 | 0.78 | GUSB (0.51) | ALDH1A1HPGDHSD17B10CYP3A4TSHR | |
| SCHEMBL52121 | 0.78 | ALDH1A1 (0.48) | ALDH1A1HPGDHSD17B10CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019163245-A1 | QUINONE ANALYSIS METHOD AND ONLINE SFE-SFC SYSTEM FOR IMPLEMENTING SAID METHOD | 株式会社島津製作所 | 2019-08-29 | — | — | WO | claimed |
| US-20240239745-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | Bilix Co., Ltd. (KR) | 2024-07-18 | — | — | US | disclosed |
| US-12024658-B2 | Water-based hybrid pressure sensitive adhesive composition and method of producing the same | DOW SILICONES CORPORATION (US) | 2024-07-02 | — | — | US | disclosed |
| EP-4375280-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | Bilix Co., Ltd. (KR) | 2024-05-29 | — | — | EP | disclosed |
| EP-4371984-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | Bilix Co., Ltd. (KR) | 2024-05-22 | — | — | EP | disclosed |
| EP-4371985-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | Bilix Co., Ltd. (KR) | 2024-05-22 | — | — | EP | disclosed |
| EP-3771731-B1 | A CURABLE HOTMELT SILICONE COMPOSITION, ENCAPSULANT, FILM AND OPTICAL SEMICONDUCTOR DEVICE | DUPONT TORAY SPECIALTY MATERIALS KK (JP) | 2024-04-17 | — | — | EP | disclosed |
| CN-117881673-A | Synthesis method of bilirubin | 株式会社毕丽斯 | 2024-04-12 | — | — | CN | disclosed |
| CN-115038757-B | Curable elastomer composition and method for designing transducer device | 陶氏东丽株式会社 | 2024-04-05 | — | — | CN | disclosed |
| CN-117836290-A | Synthesis method of bilirubin | 株式会社毕丽斯 | 2024-04-05 | — | — | CN | disclosed |
| US-20160289499-A1 | Silicone Material, Curable Silicone Composition, And Optical Device | DOW TORAY CO., LTD. (JP) | 2016-10-06 | — | — | US | disclosed |
| EP-3076443-A1 | SILICONE MATERIAL, CURABLE SILICONE COMPOSITION, AND OPTICAL DEVICE | Dow Corning Toray Co., Ltd. (JP) | 2016-10-05 | — | — | EP | disclosed |
| US-20150344735-A1 | Curable Silicone Composition, Cured Product Thereof, And Optical Semiconductor Device | DOW CORNING TORAY CO., LTD. (JP) | 2015-12-03 | — | — | US | disclosed |
| WO-2014104388-A2 | CURABLE SILICONE COMPOSITION, CURED PRODUCT THEREOF, AND OPTICAL SEMICONDUCTOR DEVICE | DOW CORNING TORAY CO., LTD. (JP) | 2014-07-03 | — | — | WO | disclosed |
| US-7812155-B2 | Process for preparing an o-alkylated rapamycin derivative and o-alkylated rapamycin derivative | TERUMO KABUSHIKI KAISHA (JP) | 2010-10-12 | — | — | US | disclosed |
| EP-2090580-A1 | PROCESS FOR PRODUCING O-ALKYLATED RAPAMYCIN DERIVATIVE, AND O-ALKYLATED RAPAMYCIN DERIVATIVE | Terumo Kabushiki Kaisha (JP) | 2009-08-19 | — | — | EP | disclosed |
| US-20080146796-A1 | Process for preparing an o-alkylated rapamycin derivative and o-alkylated rapamycin derivative | TERUMO KABUSHIKI KAISHA (JP) | 2008-06-19 | — | — | US | disclosed |
| US-20070263046-A1 | Detection apparatus using cartridge | SEKISUI CHEMICAL CO., LTD. (JP) | 2007-11-15 | — | — | US | disclosed |
| EP-1852703-A1 | DETECTION DEVICE USING CARTRIDGE | SEKISUI CHEMICAL CO., LTD. (JP) | 2007-11-07 | — | — | EP | disclosed |
| US-6303760-B1 | TRIMETALLIC NITRIDE ENDOHEDRAL METALLOFULLERENES | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | 2001-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080146796-A1 | Process for preparing an o-alkylated rapamycin derivative and o-alkylated rapamycin derivative | RICTOR, RPTOR, MTOR | ALDH1A1 4261/4885HPGD 3466/4885HSD17B10 1295/4885 |
| US-20240239745-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | CYP7A1, UGT1A3, UGT1A1 | ALDH1A1 225/4885HPGD 596/4885HSD17B10 339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.